Antonia Dimitrakopoulou-Strauss, Prof. Dr.

Summary

Affiliation: German Cancer Research Center
Location: Heidelberg, Germany

Publications

  1. pmc Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab
    Christina Marina Breki
    Institute of Nanoscience and Nanotechnology, National Center for Scientific Research Demokritos, Athens, Greece
    EJNMMI Res 6:61. 2016
  2. pmc Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial
    Vasileios Askoxylakis
    Department of Radiation Oncology, University of Heidelberg, INF 400, 69120, Heidelberg, Germany
    Radiat Oncol 7:157. 2012
  3. pmc Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line
    Caixia Cheng
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    EJNMMI Res 1:34. 2011
  4. pmc The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction
    Wilko I Staiger
    Div, Surgical Oncology and Thoracic Surgery, Department of Surgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany
    World J Surg Oncol 6:37. 2008
  5. ncbi request reprint Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo
    Johannes Hoffend
    Division of Nuclear Medicine, Department of Radiology, University of Heidelberg, 69120 Heidelberg, Germany
    Nucl Med Biol 32:287-92. 2005
  6. ncbi request reprint Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit, Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 33:823-30. 2006
  7. ncbi request reprint 18F-FDG kinetics and gene expression in giant cell tumors
    Ludwig G Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 45:1528-35. 2004
  8. pmc A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
    Thomas Schmitt
    Department of Hematology, Oncology, and Rheumatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
    BMC Cancer 11:510. 2011
  9. ncbi request reprint Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
    Antonia Dimitrakopoulou-Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 45:1480-7. 2004
  10. ncbi request reprint Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma
    Uwe Haberkorn
    Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 34:2011-23. 2007

Collaborators

Detail Information

Publications48

  1. pmc Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab
    Christina Marina Breki
    Institute of Nanoscience and Nanotechnology, National Center for Scientific Research Demokritos, Athens, Greece
    EJNMMI Res 6:61. 2016
    ....
  2. pmc Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial
    Vasileios Askoxylakis
    Department of Radiation Oncology, University of Heidelberg, INF 400, 69120, Heidelberg, Germany
    Radiat Oncol 7:157. 2012
    ..18)F-fluoromisonidazole dynamic positron emission tomography and computed tomography ((18) F-FMISO dPET-CT) and functional magnetic resonance imaging (functional MRI) are attractive options for imaging tumor hypoxia...
  3. pmc Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line
    Caixia Cheng
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    EJNMMI Res 1:34. 2011
    ..The purpose of this study was to investigate the kinetics and to compare both tracers in an experimental NET cell line...
  4. pmc The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction
    Wilko I Staiger
    Div, Surgical Oncology and Thoracic Surgery, Department of Surgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany
    World J Surg Oncol 6:37. 2008
    ..If locally advanced, extended or multivisceral resection with relevant procedural-specific morbidity and mortality is often necessary...
  5. ncbi request reprint Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo
    Johannes Hoffend
    Division of Nuclear Medicine, Department of Radiology, University of Heidelberg, 69120 Heidelberg, Germany
    Nucl Med Biol 32:287-92. 2005
    ..Our findings support clinical imaging using 68Ga-DOTA-labeled human serum albumin (HSA). The generator-produced label makes 68Ga-DOTA-labeled albumin continuously available even to centers lacking an in-house cyclotron...
  6. ncbi request reprint Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit, Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 33:823-30. 2006
    ..Furthermore, dynamic(18)F-fluorodeoxyglucose (FDG) studies were performed in the same patients to compare the SSTR2 expression with the tumour viability...
  7. ncbi request reprint 18F-FDG kinetics and gene expression in giant cell tumors
    Ludwig G Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 45:1528-35. 2004
    ..18F-FDG kinetics were evaluated by use of compartment and noncompartment models of giant cell tumors. The kinetic data were compared with the gene expression data for a subgroup of patients...
  8. pmc A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
    Thomas Schmitt
    Department of Hematology, Oncology, and Rheumatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
    BMC Cancer 11:510. 2011
    ..Here we report on the results of our non-randomized phase II study on neo-adjuvant treatment for high-risk STS...
  9. ncbi request reprint Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
    Antonia Dimitrakopoulou-Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 45:1480-7. 2004
    ....
  10. ncbi request reprint Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma
    Uwe Haberkorn
    Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 34:2011-23. 2007
    ..The aim of this study was to assess these reactions using FDG-PET and high-throughput methods such as gene profiling...
  11. ncbi request reprint Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas
    Marcus Henze
    Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    J Nucl Med 46:763-9. 2005
    ..In contrast to (18)F-FDG, this ligand shows high meningioma-to-background ratios. The aim was to evaluate kinetic parameters in meningiomas before radiotherapy...
  12. ncbi request reprint Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
    Ludwig G Strauss
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, D 69120, Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 34:868-77. 2007
    ..Dynamic PET data (DPET) were acquired, and compartment and non-compartment modelling applied. The discriminant power of single parameters and the combination of PET parameters was assessed. All lesions were confirmed by histology...
  13. doi request reprint Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography
    Bernd Kasper
    Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    Onkologie 31:107-12. 2008
    ..We used 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with soft tissue sarcoma (STS). Treatment effect was assessed with regard to prediction of therapy outcome...
  14. doi request reprint Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[(18)f]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in colorectal tumors
    Ludwig G Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Mol Imaging Biol 13:1290-300. 2011
    ..g., like angiogenesis and proliferation. The impact of cell-proliferation-related genes on the FDG kinetics was assessed in colorectal tumors in this study...
  15. ncbi request reprint Fusion of positron emission tomography (PET) and gene array data: a new approach for the correlative analysis of molecular biological and clinical data
    Ludwig G Strauss
    German Cancer Research Center, Heidelberg 69120, Germany
    IEEE Trans Med Imaging 26:804-12. 2007
    ..The GenePET program facilitates an interactive approach together with the use of key words to identify possible targets for new radiopharmaceuticals...
  16. ncbi request reprint Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes
    Pierre Kunz
    Department of Anatomy and Cell Biology III, University of Heidelberg, Heidelberg, Germany
    J Nucl Med 47:1515-24. 2006
    ..In this study we wished to examine the complex effects of angiopoietin-2 (Ang-2) gene transfer in a rat hepatoma model...
  17. ncbi request reprint Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a feasibility study
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group, Biological Imaging E0601, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
    Mol Imaging Biol 9:308-17. 2007
    ....
  18. doi request reprint Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors
    Ludwig G Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 49:1238-44. 2008
    ..The dependency of 18F-FDG kinetics on angiogenesis-related gene expression was evaluated in this study...
  19. ncbi request reprint Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Sophia Koukouraki
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 33:1115-22. 2006
    ....
  20. ncbi request reprint Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics
    Ludwig G Strauss
    Medical PET Group, Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 44:1933-9. 2003
    ..A modified short dynamic protocol was defined and evaluated to predict kinetic parameters of (18)F-FDG metabolism from a dynamic data acquisition...
  21. doi request reprint Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics
    Ludwig G Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 36:1226-34. 2009
    ..The aim of this study was to identify changes in gene expression patterns and to detect combinations of PET parameters that may be helpful in identifying treated tumours early after chemotherapy using dynamic PET studies...
  22. doi request reprint Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies
    Ludwig G Strauss
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 52:379-85. 2011
    ..The routine use of dynamic PET is limited because of this modality's 1-h acquisition time. We evaluated shortened acquisition protocols up to 0-30 min regarding the accuracy for data analysis with the 2-tissue-compartment model...
  23. ncbi request reprint Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis
    Shinichi Okazumi
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Hell J Nucl Med 12:223-8. 2009
    ..25 (P<0.0162) had significantly poor prognosis. In conclusion, the evaluation of full (18)F-FDG kinetics provides important information for the diagnosis of malignant lesions, histological grading and prognosis of soft tissue sarcomas...
  24. ncbi request reprint Treatment monitoring with 18F-FDG PET in metastatic thymoma after 90Y-Dotatoc and selective internal radiation treatment (SIRT)
    Julie Vasamiliette
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Hell J Nucl Med 12:271-3. 2009
    ..MRI of the liver demonstrated a decrease in vascularization and a modest decrease in tumor volume. Therefore, surgical resection of the primary thymoma was initiated...
  25. doi request reprint Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumours
    Dimitris J Apostolopoulos
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, DKFZ, Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 38:1212-23. 2011
    ..The aim of the present study was to investigate the value of parametric images generated after dynamic data acquisition for the detection of active liver metastases...
  26. doi request reprint Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arrays
    Ludwig G Strauss
    Medical PET Group Biological Imaging E060 1, CCU Nuclear Medicine, German Cancer Research Center, 69120, Heidelberg, Germany
    Mol Imaging Biol 14:376-83. 2012
    ..The primary aim of this study was the correlation of receptor expression and tracer kinetics...
  27. ncbi request reprint The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions
    Antonia Dimitrakopoulou-Strauss
    Division of Oncological Diagnostics and Therapy, German Cancer Research Center, E0105 Medical PET Group, Im Neuenheimer Feld 280, Heidelberg, D 69120 Germany
    J Nucl Med 43:510-8. 2002
    ..The role of quantitative (18)F-FDG PET studies for the differentiation of benign and malignant bone lesions is still an open question...
  28. ncbi request reprint Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Sophia Koukouraki
    Medical PET Group, Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 33:460-6. 2006
    ..i...
  29. ncbi request reprint Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells
    Uwe Haberkorn
    Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
    J Nucl Med 45:827-33. 2004
    ..This study evaluates the iodide kinetics and dosimetry of iodide in hNIS-expressing thyroid carcinoma cells under optimized conditions...
  30. pmc Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas
    Matthias H M Schwarzbach
    Department of Surgery, University of Heidelberg, Heidelberg, Germany
    Ann Surg 241:286-94. 2005
    ....
  31. ncbi request reprint Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography/computed tomography
    Mustafa Takesh
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Hell J Nucl Med 15:63-5. 2012
    ..In conclusion, this case suggests that ¹⁸F-FECH PET/CT study can show positive findings in sarcoidosis that were no longer detectable after two years, suggestive of spontaneous recovery...
  32. ncbi request reprint Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging Clinical Cooperation, Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Hell J Nucl Med 9:10-21. 2006
    ..Furthermore, the parametric imaging including Fourier-analysis and regressions analysis was used...
  33. ncbi request reprint Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET
    Marcus Henze
    Clinical Cooperation Unit, Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 31:466. 2004
  34. ncbi request reprint Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG
    Caixa Cheng
    Clinical Cooperation Unit, Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, D 69120 Heidelberg, Germany
    Hell J Nucl Med 14:15-20. 2011
    ..In conclusion, the results revealed that cilengitide treatment of experimental breast cancer bone metastases had a significant therapeutic impact on (18)F-FDG kinetics...
  35. doi request reprint Positron emission tomography (PET) and macromolecular delivery in vivo
    Ludwig G Strauss
    Medical PET Group, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Methods Mol Biol 480:187-98. 2009
    ..This bombesin analogue, (68)Ga-BZH3, is used in patients with GIST...
  36. ncbi request reprint 18F-FDG PET in a 10-year-old female patient with subacute sclerosing panencephalitis
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 33:1100-1. 2006
  37. pmc Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumors
    Ludwig G Strauss
    Medical PET Group, Biological Imaging, CCU Nuclear Medicine, German Cancer Research Center, 69120 Heidelberg, Germany
    ScientificWorldJournal 2012:721313. 2012
    ..The results obtained with dynamic PET (dPET) were compared to gene expression data obtained in patients with gastrointestinal stromal tumors (GIST). The primary aim was to assess the association of the dPET results and gene expression data...
  38. ncbi request reprint A new approach for the development of tracers: data base screening and in silico modeling for the identification of new ligands for SSTR2
    Caixia Cheng
    Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, Germany
    Hell J Nucl Med 11:101-4. 2008
    ..In conclusion, the use of a focused library that incorporates an initial probe, improved the possibility of a successful virtual screening as compared with random screening and is cost efficient by further combination of trial docking...
  39. ncbi request reprint The role of PET in head and neck cancer
    Ludwig G Strauss
    Medical PET Group Biological Imaging Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, D 69120 Heidelberg, Germany
    Hell J Nucl Med 11:6-11. 2008
    ..Studies in patients undergoing surgery and radiotherapy demonstrated, that PET with (18)F-FDG can be used for the prediction of individual survival...
  40. ncbi request reprint Angiostatin overexpression in Morris hepatoma results in decreased tumor growth but increased perfusion and vascularization
    Kerstin Schmidt
    Department of Anatomy and Cell Biology III, University of Heidelberg, INF 307, Heidelberg, Germany
    J Nucl Med 47:543-51. 2006
    ..Human angiostatin (hANG) is one of the most potent inhibitors of endothelial cell proliferation, angiogenesis, and tumor growth in vivo. However, its mechanisms operating in vivo are not well understood...
  41. pmc Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Cancer Imaging 12:283-9. 2012
    ..The aim is to present quantification approaches that can be used for the evaluation of dPET/CT series in combination with parametric imaging and to demonstrate the feasibility with regard to tumour diagnostics and therapy management...
  42. doi request reprint Dynamic PET with FDG in patients with unresectable aggressive fibromatosis: regression-based parametric images and correlation to the FDG kinetics based on a 2-tissue compartment model
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German
    Clin Nucl Med 37:943-8. 2012
    ..A comparison between the regression-based quantitative data (slope and intercept values) with the compartmental data of FDG was performed...
  43. ncbi request reprint Parametric imaging: a promising approach for the evaluation of dynamic PET-18F-FDG studies - the DKFZ experience
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit, Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Hell J Nucl Med 13:18-22. 2010
    ....
  44. doi request reprint Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Clin Nucl Med 36:101-8. 2011
    ..Furthermore, dynamic F-18 Fluorodeoxyglucose (FDG) studies were performed for comparison...
  45. doi request reprint Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 51:551-8. 2010
    ..The goal of the study was to evaluate the impact of early dPET studies and assess their value with regard to the therapy outcome using histopathologic data...
  46. doi request reprint Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging E0601, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Eur J Nucl Med Mol Imaging 37:1481-9. 2010
    ..The goal of the study was to evaluate the impact of full kinetic analysis and assess its value with regard to the therapy outcome based on survival data...
  47. doi request reprint Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    Clin Nucl Med 34:576-84. 2009
    ....
  48. ncbi request reprint 68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG
    Antonia Dimitrakopoulou-Strauss
    Medical PET Group Biological Imaging, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
    J Nucl Med 48:1245-50. 2007
    ..Furthermore, dynamic 18F-FDG studies were performed on the same patients...